Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...
Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...
Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease Ambry Genetics first implemented RNA testing in 2016 as part of a research and ...
SAINT LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced the publication of their analytical validation study of ...
A research team's new technique could help scientists worldwide identify novel targets for cancer therapies. Every writer needs a good editor. That's true for the publishing business, but it's also ...
Live-cell breakthrough: Munich scientists created a method to repeatedly read genetic activity from living cells, enabling long-term study without cell destruction. CRISPR reimagined: Hong Kong ...
7don MSN
RNA biomarkers identified that could offer a simple blood test for earlier Alzheimer's diagnosis
Mount Sinai researchers have discovered blood RNA biomarkers that offer a promising, minimally invasive approach for earlier ...
The development of non-invasive diagnostic methods for zoonotic viral infections is important for animal welfare and public health. Sebum-based diagnostic methods using commercial oil-blotting films ...
Spinal cord injury (SCI)-induced neuropathic pain remains difficult to treat. Given the high risk of using opioid analgesics as a primary treatment option, developing non-opioid therapeutic candidates ...
Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results